HC Wainwright & Co. Reiterates Buy on Verastem, Maintains $7 Price Target

Benzinga · 10/18 11:20
HC Wainwright & Co. analyst Sean Lee reiterates Verastem (NASDAQ:VSTM) with a Buy and maintains $7 price target.